Business
Moderna’s Stock Tumbles After Data Leak Rumors
Moderna's stock is experiencing a significant drop after reports of leaked data for their experimental cancer vaccine. The company and Merck are set to share Phase 3 data at an upcoming medical conference.
Coverage timeline — 1 article
MarketWatch
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
2026-10-22 18:10 UTC